Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine
M M
MM
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore 21201, USA.
Galen
J
J
Barry
E
E
Noriega
F
F
Tacket
C
C
Sztein
M
M
Chatfield
S
S
Dougan
G
G
Losonsky
G
G
Kotloff
K
K
D000284:Administration, Oral; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage; D004405:Dysentery, Bacillary / Q000276:immunology / Q000517:prevention & control; D004768:Enterotoxins / Q000235:genetics / Q000276:immunology; D005798:Genes, Bacterial; D006801:Humans; D012485:Salmonella typhi / Q000235:genetics / Q000276:immunology*; D017384:Sequence Deletion; D012760:Shigella / Q000235:genetics / Q000276:immunology*; D014435:Typhoid Fever / Q000276:immunology / Q000517:prevention & control; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D019444:Vaccines, DNA
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D004768:Enterotoxins; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA